Transketolase counteracts oxidative stress to drive cancer development
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Significance: Excessive accumulation of oxidative stress is harmful to cancer cells. Our study demonstrates the important roles of a pentose phosphate pathway (PPP) enzyme, transketolase (TKT), in redox homeostasis in cancer development. We highlight the clinical relevance of TKT expression in cancers. We also show that TKT overexpression in cancer cells is a response of Nuclear Factor, Erythroid 2-Like 2 (NRF2) activation, a sensor to cellular oxidative stress. TKT locates at an important position that connects PPP with glycolysis to affect production of antioxidant NADPH. Our preclinical study shows that targeting TKT leads to elevation of oxidative stress, making cancer cells more vulnerable to therapeutic treatment, such as Sorafenib. Using TKT as an example, our study suggests that targeting enzymes for antioxidant production represents a direction for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“formate triggered an upregulation of differentially expressed genes (DEGs) involved in 1C metabolism, such as serine hydroxymethyltransferase 2 (Shmt2)42,58 and cystathionine gamma-lyase (Cth)59, as well as genes regulated by Nrf2 (e.g.: Cth60, NADH dehydrogenase 4 (mt-Nd4)61 and transketolase (Tkt)62,63) (Figure 6L and Table S3).”
From Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy (2025) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“In the past decade, tremendous efforts have been made to provide molecular explanations for the Warburg Effect, which was reported 60 y ago (19).”
BackgroundDietary Carcinogens and Anticarcinogens: Oxygen radicals and degenerative diseases
Ames, B. N. (1983) · Science · doi:10.1126/science.6351251 · Cited by 2,969
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Low activity of pyruvate kinase reduces the entrance of pyruvate into the TCA cycle, thereby decelerating the metabolic flux of the TCA cycle and allowing TCA cycle intermediates to be synthesized into biomass, such as lipid (22).”
BackgroundPhysiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277 · cited 1×
“NRF2 is characterized as an oncogene for its ability to buffer ROS (28).”
BackgroundNrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 3×
“Recently, NRF2 has been reported to transcriptionally activate some PPP genes, such as TKT, G6PD, and TALDO (13).”
BackgroundResultInfluentialQuantitative flux analysis reveals folate-dependent NADPH production
Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., & Rabinowitz, J. D. (2014) · Nature · doi:10.1038/nature13236 · Cited by 1,114 · cited 2×
“G6PD deficiency has not been found to be protective against cancers, possibly because of the compensatory effects from other NADPH-producing enzymes (20, 34, 35).”
BackgroundAntioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · cited 1×
“Antioxidants have been shown to confer cancer stem cells’ radio resistance (30) and promote anchorage-independent growth of cancer cells (31).”
BackgroundPyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995 · cited 7×
“Further knowledge on the interplay of TKT and PKM2 will help to devise combined therapies against the PPP and glycolysis for cancer patients.”
BackgroundInfluentialHarris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993
Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis
Hampton, M. B., & Orrenius, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01068-5 · Cited by 660
(1998) · British Journal of Cancer · doi:10.1038/bjc.1998.1 · Cited by 654
Hemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 gene
Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf516 · Cited by 637 · cited 2×
“BACH1 is known to be an important regulator of oxidative stress through repressing heme oxygenase 1 (HMOX1), which degrades heme to form bilirubin, a strong ROS scavenger (11).”
BackgroundDhakshinamoorthy, S., Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500166200 · Cited by 414 · cited 1×
“BACH1 has been shown to inhibit an antioxidant gene, NAD(P)H dehydrogenase, quinone 1 (NQO1), through competitive binding with a transcriptional activator, Nuclear Factor, Erythroid 2-Like 2 (NRF2) (12).”
BackgroundIDH mutations in glioma and acute myeloid leukemia
Dang, L., Jin, S., & Su, S. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.002 · Cited by 370
Wong, C. C.-L., Tse, A. P.-W., Huang, Y.-P., Zhu, Y.-T., Chiu, D. K.-C., Lai, R. K.-H., Au, S. L.-K., Kai, A. K.-L., Lee, J. M.-F., Wei, L. L., et al. (2014) · Hepatology · doi:10.1002/hep.27320 · Cited by 253
Self-citationTAp73 enhances the pentose phosphate pathway and supports cell proliferation
Du, W., Jiang, P., Mancuso, A., Stonestrom, A., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 233
Perl, A., Hanczko, R., Telarico, T., Oaks, Z., & Landas, S. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.014 · Cited by 204
Coriat, R., Nicco, C., Chéreau, C., Mir, O., Alexandre, J., Ropert, S., Weill, B., Chaussade, S., Goldwasser, F., & Batteux, F. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0093 · Cited by 199
Warnatz, H.-J., Schmidt, D., Manke, T., Piccini, I., Sultan, M., Borodina, T., Balzereit, D., Wruck, W., Soldatov, A., Vingron, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220178 · Cited by 188
Redox regulation of cancer cell migration and invasion
Tochhawng, L., Deng, S., Pervaiz, S., & Yap, C. T. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.08.002 · Cited by 180
Zhao, F., Mancuso, A., Bui, T. V., Tong, X., Gruber, J. J., Swider, C. R., Sanchez, P. V., Lum, J. J., Sayed, N., Melo, J. V., et al. (2010) · Oncogene · doi:10.1038/onc.2010.67 · Cited by 179
Ng, I. O. L., Lai, E. C. S., Fan, S. T., Ng, M. M. T., & So, M. K. P. (1995) · Cancer · doi:10.1002/1097-0142(19951215)76:12<2443::aid-cncr2820761207>3.0.co;2-f · Cited by 152
Self-citationLiver Transplantation for Malignancy
Hertl, M., & Cosimi, A. B. (2005) · The Oncologist · doi:10.1634/theoncologist.10-4-269 · Cited by 149
Xu, X., zur Hausen, A., Coy, J. F., & Löchelt, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24078 · Cited by 147
Ramos‐Montoya, A., Lee, W. P., Bassilian, S., Lim, S., Trebukhina, R. V., Kazhyna, M. V., Ciudad, C. J., Noé, V., Centelles, J. J., & Cascante, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22227 · Cited by 135
Bagga, D., Ashley, J. M., Geffrey, S. P., Wang, H.-J., Barnard, R. J., Korenman, S. G., & Heber, D. (1995) · Cancer · doi:10.1002/1097-0142(19951215)76:12<2565::aid-cncr2820761224>3.0.co;2-b · Cited by 104
Wong, C. C., Au, S. L., Tse, A. P., Xu, M., Lai, R. K., Chiu, D. K., Wei, L. L., Fan, D. N.-Y., Tsang, F. H., Lo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115036 · Cited by 92
Self-citationA critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation
Jiang, P., Du, W., & Yang, X. (2013) · Cell Cycle · doi:10.4161/cc.27267 · Cited by 72
Chen, H., Yue, J., Yang, S., Ding, H., Zhao, R., & Zhang, S. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-43 · Cited by 59
Diaz-Moralli, S., Tarrado-Castellarnau, M., Alenda, C., Castells, A., & Cascante, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025323 · Cited by 53
Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer
Staiger, W., Coy, J., Grobholz, R., Hofheinz, R., Lukan, N., Post, S., Schwarzbach, M., & Willeke, F. (2006) · Oncology Reports · doi:10.3892/or.16.4.657 · Cited by 47
TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens
Schultz, H., Kähler, D., Branscheid, D., Vollmer, E., Zabel, P., & Goldmann, T. (2008) · Diagnostic Pathology · doi:10.1186/1746-1596-3-35 · Cited by 45
Does G6PD deficiency protect against cancer? A critical review.
Cocco, P. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.2.89 · Cited by 38
Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.
Krockenberger, M., Engel, J. B., Schmidt, M., Kohrenhagen, N., Häusler, S. F., Dombrowski, Y., Kapp, M., Dietl, J., & Hönig, A. (2010) · PubMed · Cited by 35
Overall kinetic mechanism of 6-phosphogluconate dehydrogenase from Candida utilis
Berdis, A. J., & Cook, P. F. (1993) · Biochemistry · doi:10.1021/bi00059a021 · Cited by 29
Cited by
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 643
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
“…with Han volunteers, a significant difference in genotypic and allelic frequencies of four SNPs of the NFE2L2 gene was found between T2DM patients with and without complications, including peripheral neuropathy, nephropathy, retinopathy, foot ulcers, and microangiopathy (Xu et al., 2016b).”
BackgroundMechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 615
Metabolic heterogeneity confers differences in melanoma metastatic potential
Tasdogan, A., Faubert, B., Ramesh, V., Ubellacker, J. M., Shen, B., Solmonson, A., Murphy, M. M., Gu, Z., Gu, W., Martin, M., et al. (2020) · Nature · doi:10.1038/s41586-019-1847-2 · Cited by 509
Wei, L., Lee, D., Law, C.-T., Zhang, M. S., Shen, J., Chin, D. W.-C., Zhang, A., Tsang, F. H.-C., Wong, C. L.-S., Ng, I. O.-L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12606-7 · Cited by 428
Self-citation
Metadata
- Authors
- Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., Law, C.-T., Wong, C.-M., Cai, Z., Wong, C. C.-L., & Ng, I. O.-L.
- Affiliations
- Department of Pathology, The University of Hong Kong, Hong Kong, SAR, China;
- University of Hong Kong (HK)
- Department of Chemistry,Hong Kong Baptist University, Hong Kong, SAR, China;
- Hong Kong Baptist University (HK)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-01-25
- Volume
- 113
- Issue
- 6
- Pages
- E725-34
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4760787
- OpenAlex
- W2267831227
- Cited by
- 251
- References
- 39
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 23 · 2023: 25 · 2022: 29 · 2021: 30 · 2020: 24 · 2019: 22 · 2018: 25 · 2017: 20 · 2016: 11
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Funders
- Health and Medican Research Fund (02132696)
- National Natural Science Foundation of China (NSFC-21377106)
- Hong Kong Research Grant Council Collaborative Research Fund (HKBU/CRF/10)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- transketolase, oxidative stress, pentose phosphate pathway, NADPH, tumor growth, redox homeostasis, sorafenib sensitivity, antioxidant metabolism, cancer therapy
- MeSH terms
- Sorafenib, Animals, Base Sequence, Female, Glucose, Glutathione, Glycolysis, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Nude, Molecular Sequence Data, Niacinamide, Pentose Phosphate Pathway, Peroxides, Phenylurea Compounds, RNA, Messenger, Transketolase, Up-Regulation, Cell Death, Reactive Oxygen Species, Oxidative Stress, Cell Line, Tumor, Cell Proliferation, Metabolome, Gene Knockdown Techniques, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.